Author Archive

Wow. Agios’ Experimental Leukemia Drug Makes Cancer Undetectable In Three Patients

Agios, a biotechnology company based in Cambridge, Mass., has seemed in some ways a sign of the overexcitement of the recent biotech boom. After all, the company, despite an experienced management team, a July public stock offering

Whither Japan Stocks: Looking For Opportunities In The ‘Post-Abenomics’ Market

Sell side analysts always find something bullish to say about the market. For investors the watchword is caveat emptor.  As an investor, what to think about Japanese stocks now? It should go without saying that Japan’s mainstream

Worried About Measles? Don’t Call Dr. Bob Sears

Dr. Bob Sears once wrote a non-evidence-based book about vaccines, urging parents to adopt “Dr. Bob’s Alternative Vaccine Schedule (TM?)” but at the least, to please purchase his book. Thousands of people, presumably terrified at the prospect

Hundreds Drop Resumes at Colorado’s First Cannabis Career Fair

This week marked a first for Colorado and the cannabis industry as a whole: its first ever job fair. The event was held in the downtown Denver headquarters of cannabis vaporizing device manufacturer O.penVAPE which organized the

Clock Is Ticking For AstraZeneca

This morning Eli Lilly Co Eli Lilly Co. (LLY) released top-line results for the sixth AWARD study for their once-weekly GLP-1 dulaglutide. According to a company issued press release; “In the AWARD-6 study, once-weekly dulaglutide 1.5 mg

Apple Store Model Boosts Health Care Enrollment In Connecticut

Ask a person who their role models are and you’ll learn a lot about their character. You will also learn how successful they are likely to be. In September I wrote this column about Connecticut’s health insurance

Autism, Chloride, And Oxytocin: 5 Caveats

A new study published in the sci-glam journal Science purports to point to a way to prevent or “treat” autism in utero by way of oxytocin-related therapeutics. But where the findings really point, if one takes them

SURPRISE: Massachusetts Is Home To America’s Worst-Performing ObamaCare Exchange

Massachusetts is struggling under ObamaCare. In the state that “inspired” the Affordable Care Act (ACA), with almost universal coverage and a functional exchange, most would assume the transition to the federal law would be largely cosmetic. Yet

The Era Of Genetically-Altered Humans Could Begin This Year

By the middle of 2014, the prospect of altering DNA to produce a genetically-modified human could move from science fiction to science reality.  At some point between now and July, the UK parliament is likely to vote

Davos: A High Old Time For CEOs

Davos is the place to be for the world’s top executives and political figures this week but what happens if you’re not deemed important enough to get in? Here’s my tale from nine years ago. This way